Substance Records - Expert Committee on Drug Dependence Information Repository

( (7) | 1 (12) | 2 (16) | 3 (18) | 4 (21) | 5 (10) | 6 (2) | 7 (2) | A (33) | B (23) | C (22) | D (32) | E (13) | F (14) | G (3) | H (6) | I (1) | J (3) | K (4) | L (5) | M (33) | N (26) | O (5) | P (32) | Q (1) | R (2) | S (3) | T (16) | U (2) | V (3) | X (1) | Z (4)

Title	Drug Class	Year(s) and type of review / ECDD meetings
5,6-methylenedioxy-2-aminoindane	stimulant	Added to surveillance list by 2nd WG meeting (2017)
5-APB 5-(2-aminopropyl)benzofuran	stimulant	Added to surveillance list by 2nd WG meeting (2017)
5-MAPB	stimulant	Added to surveillance list by 2nd WG meeting (2017)
5-Methoxy-3,4-methylenedioxyamphetamine	stimulant	22nd ECDD (1985) - Critical review
5-Methoxy-N,N-diallyltryptamine	hallucinogen	43rd ECDD (2020) - Critical review
5F-ADB/5F-MDMB-PINACA	cannabinoid	39th ECDD (2017) - Critical review
5F-AMB-PINACA	cannabinoid	42nd ECDD (2019) - Critical review
5F-APINACA (5F-AKB-48)	cannabinoid	38th ECDD (2016)- Critical Review
5F-MDMB-PICA	cannabinoid	42nd ECDD (2019) - Critical review
5F-PB-22	cannabinoid	39th ECDD (2017) - Critical review